GLUT1依赖的糖酵解促进系统性红斑狼疮中CaMK4表达
该研究探讨免疫代谢在系统性红斑狼疮(SLE)中的意义及钙/钙调蛋白依赖性蛋白激酶4(CaMK4)对T细胞代谢的影响。代谢组学显示CaMK4抑制剂降低MRL/lpr小鼠初始T细胞糖酵解中间产物;活动性SLE患者效应记忆CD4+ T细胞GLUT1和CaMK4表达升高,抑制CaMK4减少Th17分化中GLUT1表达及IL-17产生。
要点
- CaMK4抑制降低糖酵解中间产物,不影响磷酸戊糖途径中间产物。
- 活动性SLE患者效应记忆CD4+ T细胞GLUT1和CaMK4表达显著升高。
- 抑制CaMK4降低Th17细胞分化中GLUT1表达及IL-17产生。
核心结论
- CaMK4活性可能驱动糖酵解并促进IL-17产生,且CaMK4可能参与活动性SLE患者T细胞GLUT1的异常表达。
研究设计与样本
- 对经抗CD3/CD28抗体处理、加或不加CaMK4抑制剂KN-93的MRL/lpr小鼠初始T细胞进行毛细管电泳质谱代谢组学分析。
- 用流式细胞术和定量聚合酶链反应检测健康对照(n=16)、非活动性SLE患者(n=13)和活动性SLE患者(n=14)CD4+ T细胞中GLUT1和CaMK4表达。
- 体外实验确定KN-93对SLE患者T细胞Th17细胞分化过程中GLUT1表达的影响。
主要发现
- CaMK4抑制显著降低葡萄糖-6-磷酸、果糖-6-磷酸、果糖-1,6-二磷酸、丙酮酸和乳酸水平(P < 0.05),但不影响6-磷酸葡萄糖酸、核酮糖-5-磷酸、核糖-5-磷酸和磷酸核糖焦磷酸水平。
- 活动性SLE患者效应记忆CD4+ T细胞GLUT1和CaMK4表达显著高于健康对照(分别为P < 0.01和P < 0.05)及非活动性SLE患者(分别为P < 0.05和P < 0.01)。
- CaMK4抑制降低Th17细胞分化过程中GLUT1表达(P < 0.01),并减少白细胞介素-17(IL-17)产生(P < 0.05)。
临床怎么用
- CaMK4和GLUT1可能作为活动性SLE中T细胞代谢异常的潜在干预靶点,但需进一步临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To clarify the significance of immunometabolism in systemic lupus erythematosus (SLE), and to determine the effect of calcium/calmodulin-dependent protein kinase 4 (CaMK4) on T cell metabolism. METHODS: Metabolomic profiling was performed using capillary electrophoresis mass spectrometry in naive T cells from MRL/lpr mice treated with anti-CD3/CD28 antibodies in the absence or presence of a CaMK4 inhibitor (KN-93). The expression of GLUT1 and CaMK4 in CD4+ T cells from healthy controls (n = 16), patients with inactive SLE (n = 13), and patients with active SLE (n = 14) was examined by flow cytometry and quantitative polymerase chain reaction. In vitro experiments were performed to determine the effect of KN-93 on the expression of GLUT1 during Th17 cell differentiation in T cells from patients with SLE. RESULTS: CaMK4 inhibition significantly decreased the levels of glycolytic intermediates such as glucose-6-phosphate, fructose-6-phosphate, fructose-1,6-diphosphate, pyruvate, and lactate (P < 0.05), whereas it did not affect the levels of the pentose phosphate pathway intermediates such as 6-phospho-d-gluconate, ribulose-5-phosphate, ribose-5-phosphate, and phosphoribosyl pyrophosphate. The expression levels of GLUT1 and CaMK4 in effector memory CD4+ T cells were significantly higher in patients with active SLE compared to healthy controls (P < 0.01 and P < 0.05, respectively) and patients with inactive SLE (P < 0.05 and P < 0.01, respectively). A functional analysis revealed that CaMK4 inhibition decreased the expression of GLUT1 during Th17 cell differentiation (P < 0.01), followed by a reduction of interleukin-17 (IL-17) production (P < 0.05). CONCLUSION: The results of the study indicate that the activity of CaMK4 could be responsible for glycolysis, which contributes to the production of IL-17, and CaMK4 may contribute to aberrant expression of GLUT1 in T cells from patients with active SLE.
引用
- Koga T, Sato T, Furukawa K, et al. Promotion of Calcium/Calmodulin-Dependent Protein Kinase 4 by GLUT1-Dependent Glycolysis in Systemic Lupus Erythematosus. Arthritis Rheumatol. 2019. PMID: 30462889. doi:10.1002/art.40785
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。